Inducible tissue constructs and uses thereof
US-2024287463-A1 · Aug 29, 2024 · US
US10478526B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10478526-B2 |
| Application number | US-201414888613-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2014 |
| Priority date | May 3, 2013 |
| Publication date | Nov 19, 2019 |
| Grant date | Nov 19, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention provides compositions in the form of skin substitutes comprising epithelial cells and mesenchymal cells, wherein the mesenchymal cells are not isolated from the occipital or nape region of the scalp, as well as methods for using the same.
Opening claim text (preview).
What is claimed is: 1. A skin substitute comprising, in a suspension, (i) epithelial cells; and (ii) isolated mesenchymal cells that are derived from the temporal region of a scalp, wherein the skin substitute induces hair follicle neogenesis. 2. The skin substitute of claim 1 , wherein the skin substitute is provided in a microsphere. 3. The skin substitute of claim 1 , wherein the suspension comprises a matrix. 4. The skin substitute of claim 3 , wherein the matrix is a collagen matrix. 5. The skin substitute of claim 1 , wherein the isolated mesenchymal cells are hair follicle dermal cells. 6. The skin substitute of claim 5 , wherein the hair follicle dermal cells are neural crest-derived cells, dermal papilla cells, or dermal sheath cells. 7. The skin substitute of claim 1 , wherein the epithelial cells are keratinocytes. 8. The skin substitute of claim 1 , wherein the epithelial cells are from a first or second passage and/or the isolated mesenchymal cells are from a first, second, third, or fourth passage. 9. The skin substitute of claim 1 , wherein the epithelial cells and the isolated mesenchymal cells are passaged in keratinocyte-conditioned medium. 10. The skin substitute of claim 1 , wherein the epithelial cells and the isolated mesenchymal cells are human. 11. The skin substitute of claim 1 , wherein the isolated mesenchymal cells are genetically unmodified mesenchymal cells. 12. A method for inducing hair follicle neogenesis, comprising delivering the skin substitute of claim 1 to a human subject, wherein the human subject has partial-thickness skin loss, full-thickness skin loss, a wound, a burn, a scar, or hair loss.
for baldness or alopecia · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Drugs for dermatological disorders · CPC title
Materials for use in artificial skin · CPC title
Epithelial cells, e.g. keratinocytes, urothelial cells · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.